Rating
Buy
Price target
$310
Previous
Implied upside
+28%

UBS analyst Timothy Arcuri reiterated a Buy rating and $310 price target on Marvell (NASDAQ: MRVL) on August 28, 2026.

“MRVL delivered a modest beat/raise, though we suspect the result was viewed more as a meet rather than beat by an investor base that had grown increasingly constructive into the print amid strong optical/interconnect commentary across the group and heightened expectations following the recently announced $120B Google warrant.

MRVL increased FY27 revenue expectations by ~$0.5B and FY28 by ~$1.5B, driven by stronger interconnect/optical trends, improving confidence in key custom ASIC programs, and continued momentum in switching.

Even so, we suspect much of this was already reflected in buy-side models.

Importantly, Google commentary remained skewed toward XPU attach, with limited incremental detail on the inference accelerator itself and a discussion of the range of outcomes deferred to the October 6 Analyst Day.

Management also noted that Google warrant programs shipping in FY27/FY28 are already largely reflected in the outlook, with more meaningful upside expected in FY29 and beyond.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Share

Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.